Factors influencing decisions by critical care physicians to withdraw life-sustaining treatments in critically ill adult patients with severe traumatic brain injury
Alexis F. Turgeon(Université Laval), Janet E. Squires(University of Ottawa), Amélie Boutin, François Lauzier(Victim Support), Karen E. A. Burns(St. Michael's Hospital), Shane English(University of Ottawa), François Lamontagne(Université de Sherbrooke), Ryan Zarychanski(CancerCare Manitoba), Lynne Moore, Donald Griesdale(Vancouver General Hospital), Kristin Dorrance(Ottawa Hospital), John Muscedere(Dalhousie University), Janet Yamada(Toronto Metropolitan University), Damon C. Scales(Health Sciences Centre), Robert Fowler(Sunnybrook Health Science Centre), Lauralyn A. McIntyre(University of Alberta), Patrick Archambault(Université Laval), Jacques Lacroix(Centre Hospitalier Universitaire Sainte-Justine), Françis Bernard(Hôpital du Sacré-Cœur de Montréal)
Cited by 36
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
What is an intensive care unit? A report of the task force of the World Federation of Societies of Intensive and Critical Care Medicine
|Journal of Critical Care|2016|841
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589